Parameter | All patients (n = 240) | Non-anemic (n = 112) | Anemic (n = 128) | p value |
---|---|---|---|---|
Age (years) | 69 (62–75) | 68 (61–73) | 71 (65–76) | 0.004 |
Sex | 0.145 | |||
Male | 176 (73.3) | 77 (68.8) | 99 (77.3) | |
Female | 64 (26.7) | 35 (31.2) | 29 (22.7) | |
BMI | 25.5 (22.8–28.4) | 25.8 (23.8–28.8) | 24.9 (22.5–27.8) | 0.054 |
Missing data | 20 | 10 | 10 | |
ASA score | 0.024 | |||
I | 28 (11.8) | 19 (17.3) | 9 (7.1) | |
II | 120 (50.6) | 57 (51.8) | 63 (49.6) | |
III | 86 (36.3) | 32 (29.1) | 54 (42.5) | |
IV | 3 (1.3) | 2 (1.8) | 1 (0.8) | |
Missing data | 3 | 2 | 1 | |
Prior heart attack | 33 (13.8) | 15 (13.4) | 18 (14.1) | 1 |
Hypertonia | 104 (43.3) | 51 (45.5) | 53 (41.4) | 0.602 |
Atrial fibrillation | 19 (7.9) | 8 (7.1) | 11 (8.6) | 0.812 |
Asthma/COPD | 17 (7.1) | 11 (9.8) | 6 (4.7) | 0.137 |
Diabetes mellitus | 29 (12.1) | 13 (11.6) | 16 (12.5) | 0.845 |
Hydronephrosis | 63 (26.3) | 19 (17) | 44 (34.4) | 0.003 |
Neoadjuvant chemotherapy | 87 (36.3) | 17 (15.2) | 70 (54.7) | <0.001 |
EBL (mL) | 1000 (700–1712.5) | 1200 (725–2000) | 1000 (650–1475) | 0.035 |
Missing data | 26 | 15 | 11 | |
Units of PBT | 4 (2–6) | 2 (1–6) | 4 (2–6) | 0.003 |
cT | 0.017 | |||
cT2 | 178 (72.2) | 92 (82.1) | 86 (67.2) | |
cT3 | 51 (21.3) | 18 (16.1) | 33 (25.8) | |
cT4 | 11 (4.6) | 2 (1.8) | 9 (7.0) | |
Year of surgery | 0.469 | |||
2001–2002 | 20 (8.3) | 12 (10.7) | 8 (6.3) | |
2003–2005 | 43 (17.9) | 21 (18.8) | 22 (17.2) | |
2006–2008 | 55 (22.9) | 27 (24.1) | 28 (21.9) | |
2009–2011 | 73 (30.4) | 34 (30.4) | 39 (30.5) | |
2012–2014 | 49 (20.4) | 18 (16.1) | 31 (24.2) |